Quantitative RT-PCR was performed to assess viral mRNA transcripts from infected ferret tracheal and lung samples used for sequencing. Total RNAs were treated with DNase using DNA-free DNase Treatment and Removal Reagents (Ambion, Inc, Austin, TX). cDNAs from total RNAs were generated using the QuantiTect reverse transcription kit (Qiagen Inc.). A custom-designed TaqMan gene expression assay for influenza Matrix (M) sequence (MPCONS2010), with primers that have complete homology with both 1918 and CA04 M sequences, was ordered from Applied Biosystems, Inc. Taqman experiments were performed on the ABI 7500 Real-Time PCR System platform and each sample was run in quadruplicate. Ribosomal RNA (18S) was used as endogenous control to normalize quantification of each target within tissues using Applied Biosystems Sequence Detections Software version 1.3. The relative amount of viral mRNA (log 10) is presented in the final results.
Taqman gene expression assay for influenza matrix
Manufactured by Thermo Fisher Scientific
The TaqMan gene expression assay for influenza Matrix is a quantitative real-time PCR (qRT-PCR) assay designed to detect and quantify the matrix gene of influenza viruses. It provides a standardized, reliable, and sensitive method for the detection of influenza virus genetic material in samples.
Automatically generated - may contain errors
Lab products found in correlation
Dnase treatment and removal reagent, by Thermo Fisher Scientific (2 mentions)
Abi 7500 real time pcr system platform, by Thermo Fisher Scientific (2 mentions)
Sequence detections software version 1, by Thermo Fisher Scientific (2 mentions)
Quantitect reverse transcription kit, by Qiagen (2 mentions)
2 protocols using taqman gene expression assay for influenza matrix
1
Quantitative RT-PCR for Influenza Virus
2
Quantitative RT-PCR for Influenza Virus
Check if the same lab product or an alternative is used in the 5 most similar protocols
+ Expand
Quantitative RT-PCR was performed to assess viral mRNA transcripts from infected ferret tracheal and lung samples used for sequencing. Total RNAs were treated with DNase using DNA-free DNase Treatment and Removal Reagents (Ambion, Inc, Austin, TX). cDNAs from total RNAs were generated using the QuantiTect reverse transcription kit (Qiagen Inc.). A custom-designed TaqMan gene expression assay for influenza Matrix (M) sequence (MPCONS2010), with primers that have complete homology with both 1918 and CA04 M sequences, was ordered from Applied Biosystems, Inc. Taqman experiments were performed on the ABI 7500 Real-Time PCR System platform and each sample was run in quadruplicate. Ribosomal RNA (18S) was used as endogenous control to normalize quantification of each target within tissues using Applied Biosystems Sequence Detections Software version 1.3. The relative amount of viral mRNA (log 10) is presented in the final results.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!